alcohol on glp 1 GLP-1s Hold Promise as Treatment for Use Disorder Ozempic and Other GLP-1 Drugs
Description
The most recently approved GLP-1RA, semaglutide, which has a half-life of approximately 7 days enabling weekly dosing, has revolutionized the medical management of obesity
Journal of the American Medical Association, 312 (19), 19982009
Beneficiaries may need to meet requirements related to: Age Body mass index, or BMI A prescription for weight loss or maintaining weight reduction Use of the medication along with lifestyle modifications Other qualifying health conditions CMS guidance indicates that the program is designed for beneficiaries seeking GLP-1 medications solely to reduce excess body weight or maintain weight reduction
This aligns with the contention that this tissue exhibits an energy-replete cardiac state
This hormone stimulates insulin production and releases blood sugar, which is how the medications are effective for people with type 2 diabetes
It is administered as a daily injection, which some patients find less convenient than the weekly dosing of semaglutide
